about
P2176
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee OsteoarthritisSMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days StudyPharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With OsteoarthritisAnalgesic Effect of Intranasal Calcitonin on Patients With Fractured RibsBone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal WomenCalcitonin Gene-related Peptide Levels in Chronic MigraineNasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel DiseaseCGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody TreatmentA Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal OsteoporosisEfficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring InjuriesClinical Characteristics and Pathophysiology of Post-Traumatic HeadacheCalcitonin Pre-treatment to Improve SPECT-CT SensitivityCalcitonin for Treating X-linked HypophosphatemiaFGF-23 Suppressibility by CalcitoninPro-calcitonin for Early Detection of Septic ArthritisA Study to Assess the Disturbances in Calcitonin Gene in Patients With Gum Disease and OsteoporosisPro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic WomenA Study of Oral Calcitonin Given at Night to Healthy Postmenopausal WomenCorrelation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of MigraineCalcitonin in the Treatment of FibromyalgiaA Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal WomenHypothyroidism Treated With CalcitoninEpidural Calcitonin in Lower Limb AmputationPTH Comparison in Post Menopausal WomenA Study of the Treatment of Postmenopausal Women With OsteoporosisComparison Medications in the Treatment of Postmenopausal Women With OsteoporosisA Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin DPharmacologic Treatment of Congenital Nephrogenic Diabetes InsipidusA Study for Patients With OsteoporosisPharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal WomenEffects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal WomenEffects of Oral Salmon Calcitonin in Human OsteoarthritisCalcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal WomenPharmacologically Triggered Migraine Without Aura and NeuroimagingPhase II Study of Calcitonin for Tumoral CalcinosisProspective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual ThyrocalcitoninCGRP's Cluster Headache Inducing Abilities in Cluster Headache Patients
P4844
Q61918426-91461B4E-072F-47BB-91B1-06B18BAD7B97Q61918431-58C52E5C-47C0-4C54-8F3B-CF6D92ABC88EQ61918436-A8D64943-59AD-421F-A3D3-2AF7C0CBC53CQ61924688-06E27D18-F0F0-4136-B2EF-7ABE0DC822A0Q61933044-3EF1FE52-7BA7-484C-B73D-BFD3ABB5AAB5Q61938725-6EA02D58-79D9-47F6-887F-AB259CE0E4D1Q62104827-17CC57A9-1EA6-4973-8315-6E3C3EF8176FQ62811176-6D5ABE5A-28BF-4873-92CA-4E119C26C9B3Q63339581-62E39615-0311-48E5-B175-D0AA99D60C50Q63573527-93295464-6C05-4812-8A0E-FC5FD767C87CQ63582924-A41326CA-9998-42D9-B282-20D10879C654Q63594689-D43C5081-D940-4BF2-A205-D9BEA9C5F815Q63805259-CB0A4A8B-6F35-465B-BEC8-436A7546B44BQ63837794-25DCD12F-2677-4AA5-9574-6A9E93F3FC32Q64045382-9CE96C74-DCD0-4A6D-B7EE-9DDCA57354B7Q64221450-D59DA4CA-B85F-4C58-AC1E-E3772E7BAAF0Q64601120-361BCE53-4C46-4748-A0E1-B2110C2482AAQ64645159-4CC3C869-352A-40E4-83A0-CF2B84D7F28AQ64663926-FD5AC28E-C08F-4C64-8E1E-633461C76F82Q64708833-3585A314-9FE5-43FF-A840-7102AAFA90B1Q64715537-DCBC513E-CECC-48BD-B1FD-1419D3472DBDQ64716047-28DFBD0F-A65E-44DA-A022-130FDE05B371Q64721301-2A29CE22-1933-4F3E-AF96-7CC71FB4FB06Q64789426-ABA14696-C75F-4F7F-A012-733D827687F3Q65357755-7B1F0FEB-0A73-406F-9D80-CACBAFBD4C3CQ65379891-5D9F05E0-8B62-48BA-B39B-0CBD3A0AC9CEQ65379913-59ABD67D-ADFF-4494-9F19-6C57659E3071Q65379919-142F76C2-0837-4B32-A5FA-A35CE4831C3EQ65381823-789B0672-84CD-49CC-AE47-EAD053929D87Q65382429-85358BD4-4CC2-435C-B6D9-6321911CA9E6Q65384692-9D248525-BD9E-4D87-9E17-4D05B9A903C6Q65385311-B6A663D4-8CA3-469D-B065-DE62426AB3CBQ65386196-97088939-F4A8-41AB-8099-D146F18BB1FBQ65388923-BFEDD754-2267-4DEB-8ABB-D26A179F188CQ65474915-AA2CE0CC-F4C1-4203-8AF4-6AE7366E36E6Q65543040-B3133DC6-0BFE-4023-ACB6-86159D07E472Q66045410-58DFEBE8-117A-4211-9300-8450EBCF8B51Q66062025-5C24CF9D-92DA-4F49-A109-C6FAAAA18B3FQ66395703-5797A2DC-C3DE-43ED-9B8F-9DDA1AD05BC6Q67128236-43C60D4F-59E5-4D54-B946-D41E8D74B7ED
P4844
description
chemická sloučenina
@cs
chemische Verbindung
@de
chemische verbinding
@nl
component quimic
@oc
compost químic
@ca
composto chimico
@it
composto químico
@gl
composto químico
@pt
composto químico
@pt-br
composé chimique
@fr
name
Salmon Calcitonin
@en
type
label
Salmon Calcitonin
@en
altLabel
Calcimar
@en
Calcitonin (Salmon Synthetic)
@en
Calcitonin 1 precursor
@en
Calcitonin Salmon
@en
Calcitonin, salmon
@en
Calcitonin-salmon
@en
Cibacalcin
@en
Fortical
@en
Miacalcin
@en
Salmon calcitonin
@en
prefLabel
Salmon Calcitonin
@en
P31
P361
P3780
P486
P665
P683
P2115
N0000147052
P2175
P231
47931-85-1
P232
P2566
100.051.203
P267
P3345
P486
P652
7SFC6U2VI5